Radius Health Reports Fourth Quarter and Full Year 2017 Financial and Operating Results and Provides Business Update Pharmaceutical Investing
FibroGen Granted Fast Track Designation by U.S. FDA for Pamrevlumab Treatment Pharmaceutical Investing
Fulgent Genetics Slides 27 Percent in Q4 2017 Financial Results, Remains Positive for 2018 Genetics Investing
Paratek Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results Pharmaceutical Investing
Catalyst Biosciences Reports Fourth Quarter and Full-Year 2017 Operating & Financial Results Pharmaceutical Investing
Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2017 Financial Results Pharmaceutical Investing
iCAD Granted CE Mark Approval in Europe for PowerLook Tomo Detection 2.0 Artificial Intelligence Solution Medical Device Investing
Novartis and Pear Therapeutics to develop digital therapeutics for patients with schizophrenia and multiple sclerosis Pharmaceutical Investing
InMed Provides Update on Pharmaceutical Development Programs - Advancing Lead Drug Candidates Towards IND and Clinical Trial
InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline
